Heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2 plays a pivotal role in vitamin D receptor (VDR) signaling by acting as a vitamin D response element-binding protein (VDRE-BP) (1,2). Transcriptional regulation by the active form of vitamin D 3 , 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) involves occupancy of VDRE by VDRE-BP or 1,25(OH) 2 D 3 -bound VDR. This relationship is disrupted by over-expression of VDRE-BP and can result in a form of human hereditary vitamin D-resistant rickets (HVDRR) (3). In other words, over abundance of VDRE-BP requires that much higher levels of 1,25(OH) 2 D 3 are necessary to displace the chromatin-bound VDRE-BP to promote VDR signaling. To date studies of the interaction between VDRE-BP and VDR-mediated signaling have been restricted to analysis of CYP24A1, a classical target gene for VDR. To provide a broader perspective on the role of VDRE-BP as a determinant of vitamin D function we compared the mRNA expression profiles of control and HVDRR cells, allowing us to identify genes with dysregulated response to 1,25(OH) 2 D 3 . Genes defined in this way were then assessed for 1,25(OH) 2 D 3 and VDRE-BP sensitivity in bone-forming osteoblastic cells, thereby shedding light on the mechanisms by which VDRE-BP over-expression in a human subject is associated with rachitic bone disease. Data presented in this study provide further evidence of a role for VDRE-BP as a pivotal component of the machinery required for 1,25(OH) 2 D 3 -mediated transregulation.
METHODS:
GeneChip® Human Gene 1.0 ST DNA microarrays (Affymetrix Inc.) were processed by the UCLA DNA Microarray Core Facility. Data was obtained from biological duplicates and analyzed using the Affymetrix Expression Console™ software. Detection of statistically significant regulated genes, heatmaps and clustering were performed in CARMAweb (carmaweb.genome.tugraz.at/carma). Microarray data has been submitted to GEO (Accession Nr. GSE22523). The human DDIT4 ON-TARGETplus SMARTpool siRNA and control reagents were purchased from Thermo Scientific. Cells were transfected using the siPORT TM amine transfection agent (Applied Biosystems). ChIP experiments were performed using the ChIP-IT Express™ kit by Active Motif and the ChampionChIP™ (SABiosciences Inc.) kit. Enriched genomic DNA was measured by qPCR using ChampionChIP™ qPCR primer assays.
RESULTS SECTION:
Data defined a sub-cluster of 114 genes induced or suppressed (>1.5-fold) in WT cells after exposure to 10 nM 1,25(OH) 2 D 3 . Of these, 113 were rendered insensitive to 1,25(OH) 2 D 3 by over-expression of VDRE-BP in the HVDRR cells. Using a selection of these genes, further studies were carried out to determine whether over-expression of VDRE-BP also suppressed 1,25(OH) 2 D 3 -mediated transcription in human osteoblastic cells. Prominent amongst the VDRE-BP-regulated, 1,25(OH) 2 D 3 -responsive genes identified in osteoblast-like cells was DNA-damage-inducible transcript 4 (DDIT4), an inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway. Chromatin immunoprecipitation (ChIP) assays using 1,25(OH) 2 D 3 -treated osteoblasts confirmed that liganded VDR and VDRE-BP compete for binding to the proximal promoter region of the DDIT4 gene in a similar fashion to that observed for other 1,25(OH) 2 D 3 target genes such as CYP24A1. A role for 1,25(OH) 2 D 3 -induced DDIT4 expression in regulating mTOR signaling was confirmed by 1,25(OH) 2 D 3 -induced suppression of phosphorylated S6K1 T389 protein (a downstream target of mTOR). The functional importance for 1,25(OH) 2 D 3 responses in osteoblasts was underlined by the fact that siRNA knockdown of DDIT4 expression suppressed antiproliferative responses to 1,25(OH) 2 D 3 . These data confirm that VDRE-BP is an important component of the transcriptional apparatus required for normal 1,25(OH) 2 D 3 -VDRmediated transcription and cell function. Conversely, over-expression of VDRE-BP exerts a dominant-negative effect on transcription of many 1,25(OH) 2 D 3 -target genes.
DISCUSSION:
Characterization of VDRE-BP action in 1,25(OH) 2 D 3 -treated osteoblasts highlights an entirely novel role for vitamin D as a regulator of mTORa known 'master regulator' of cell function. DDIT4 (also known as regulated in development and DNA damage response 1 [REDD1]) affects apoptotic/differentiation outcome by repressing the mTOR signaling pathway that regulates cell cycle progression, growth and metabolism homeostasis, protein synthesis, ribosome biogenesis, the actin cytoskeleton and autophagy (4). mTOR is a member of the phosphoinositol kinase-related kinase family whose induction is regulated by phosphorylation by protein kinase B (AKT) in response to insulin, growth factor and nutrient stimulation. The mTORC1 is induced by AKT which phosphorylates and inhibits TSC1/2, leading to downstream effects on protein synthesis and cell proliferation. By contrast, DDIT4 affects mTOR outcome by acting as a repressor of the signaling pathway through tuberin, the product of the TSC2 gene. DDIT4 was originally shown to be induced in response to a variety of cellular stresses, including hypoxia, or agents that cause DNA damage. Suppression of DDIT4 by microRNA (miR) 221 has been linked to hepatocarcinogenesis in vivo (5), highlighting a potential role as a tumor suppressor. Data presented here suggest that 1,25(OH) 2 D 3 regulates the mTOR pathway downstream of growth factor-AKT by targeting DDIT4. Crucially, knockdown experiments indicate that expression of DDIT4 is essential for the osteoblastic cell proliferation and growth activity of 1,25(OH) 2 D 3 . The proposed model for vitamin Dinduced osteoblastic DDIT4 and associated suppression of mTOR may also provide a novel mechanism for the rachitic bone disease in the human subject with abnormally high levels of VDRE-BP. In view of the broad capacity for suppression of 1,25(OH) 2 D 3 -VDR signaling by VDRE-BP it is likely that many other genes associated with mineral homeostasis and bone metabolism will be affected. Data from the current study highlight suppression of osteocalcin by VDRE-BP, but other more novel targets from our array analysis may also be involved. 
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